255 related articles for article (PubMed ID: 28646562)
1. Argininosuccinate synthase 1 (ASS1): A marker of unclassified hepatocellular adenoma and high bleeding risk.
Henriet E; Abou Hammoud A; Dupuy JW; Dartigues B; Ezzoukry Z; Dugot-Senant N; Leste-Lasserre T; Pallares-Lupon N; Nikolski M; Le Bail B; Blanc JF; Balabaud C; Bioulac-Sage P; Raymond AA; Saltel F
Hepatology; 2017 Dec; 66(6):2016-2028. PubMed ID: 28646562
[TBL] [Abstract][Full Text] [Related]
2. Does Argininosuccinate Synthase 1 (ASS1) Immunohistochemistry Predict an Increased Risk of Hemorrhage for Hepatocellular Adenomas?
Lehrke HD; Van Treeck BJ; Allende D; Denham LJ; Gonzalez RS; Moreira RK; Mounajjed T; Naini BV; Smoot RL; Zreik RT; Jenkins S; Graham RP
Appl Immunohistochem Mol Morphol; 2020 Jul; 28(6):464-470. PubMed ID: 31135443
[TBL] [Abstract][Full Text] [Related]
3. Unclassified hepatocellular adenoma expressing ASS1 associated with inflammatory hepatocellular adenomas.
Frulio N; Balabaud C; Laurent C; Trillaud H; Bioulac-Sage P
Clin Res Hepatol Gastroenterol; 2019 Oct; 43(5):e63-e67. PubMed ID: 31047837
[TBL] [Abstract][Full Text] [Related]
4. Argininosuccinate synthase 1 and periportal gene expression in sonic hedgehog hepatocellular adenomas.
Nault JC; Couchy G; Caruso S; Meunier L; Caruana L; Letouzé E; Rebouissou S; Paradis V; Calderaro J; Zucman-Rossi J
Hepatology; 2018 Sep; 68(3):964-976. PubMed ID: 29572896
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I.
Calderaro J; Labrune P; Morcrette G; Rebouissou S; Franco D; Prévot S; Quaglia A; Bedossa P; Libbrecht L; Terracciano L; Smit GP; Bioulac-Sage P; Zucman-Rossi J
J Hepatol; 2013 Feb; 58(2):350-7. PubMed ID: 23046672
[TBL] [Abstract][Full Text] [Related]
6. ASS1 Overexpression: A Hallmark of Sonic Hedgehog Hepatocellular Adenomas; Recommendations for Clinical Practice.
Sala M; Gonzales D; Leste-Lasserre T; Dugot-Senant N; Paradis V; Di Tommaso S; Dupuy JW; Pitard V; Dourthe C; Sciarra A; Sempoux C; Ferrell LD; Clouston AD; Miller G; Yeh MM; Thung S; Gouw ASH; Quaglia A; Han J; Huan J; Fan C; Crawford J; Nakanuma Y; Harada K; le Bail B; Castain C; Frulio N; Trillaud H; Possenti L; Blanc JF; Chiche L; Laurent C; Balabaud C; Bioulac-Sage P; Raymond AA; Saltel F
Hepatol Commun; 2020 Jun; 4(6):809-824. PubMed ID: 32490318
[TBL] [Abstract][Full Text] [Related]
7. Proteomic Profiling of Hepatocellular Adenomas Paves the Way to Diagnostic and Prognostic Approaches.
Dourthe C; Julien C; Di Tommaso S; Dupuy JW; Dugot-Senant N; Brochard A; Le Bail B; Blanc JF; Chiche L; Balabaud C; Bioulac-Sage P; Saltel F; Raymond AA
Hepatology; 2021 Sep; 74(3):1595-1610. PubMed ID: 33754354
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular Adenoma Subtypes Based on 2017 Classification System: Exploratory Study of Gadoxetate Disodium-Enhanced MRI Features With Proposal of a Diagnostic Algorithm.
Tse JR; Felker ER; Cao JJ; Naini BV; Liang T; Lu DSK; Raman SS
AJR Am J Roentgenol; 2023 Apr; 220(4):539-550. PubMed ID: 36169546
[No Abstract] [Full Text] [Related]
9. Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers.
Bioulac-Sage P; Cubel G; Balabaud C; Zucman-Rossi J
Semin Liver Dis; 2011 Feb; 31(1):91-103. PubMed ID: 21344354
[TBL] [Abstract][Full Text] [Related]
10. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
Nault JC; Couchy G; Balabaud C; Morcrette G; Caruso S; Blanc JF; Bacq Y; Calderaro J; Paradis V; Ramos J; Scoazec JY; Gnemmi V; Sturm N; Guettier C; Fabre M; Savier E; Chiche L; Labrune P; Selves J; Wendum D; Pilati C; Laurent A; De Muret A; Le Bail B; Rebouissou S; Imbeaud S; ; Bioulac-Sage P; Letouzé E; Zucman-Rossi J
Gastroenterology; 2017 Mar; 152(4):880-894.e6. PubMed ID: 27939373
[TBL] [Abstract][Full Text] [Related]
11. Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings.
Laumonier H; Cailliez H; Balabaud C; Possenti L; Zucman-Rossi J; Bioulac-Sage P; Trillaud H
AJR Am J Roentgenol; 2012 Aug; 199(2):341-8. PubMed ID: 22826395
[TBL] [Abstract][Full Text] [Related]
12. Focal β-catenin mutation identified on formalin-fixed and paraffin-embedded inflammatory hepatocellular adenomas.
Saldarriaga J; Bisig B; Couchy G; Castain C; Zucman-Rossi J; Balabaud C; Sempoux C; Bioulac-Sage P
Histopathology; 2017 Dec; 71(6):989-993. PubMed ID: 28618047
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular adenoma management: call for shared guidelines and multidisciplinary approach.
Blanc JF; Frulio N; Chiche L; Sempoux C; Annet L; Hubert C; Gouw AS; de Jong KP; Bioulac-Sage P; Balabaud C
Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):180-7. PubMed ID: 25434466
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience.
Bioulac-Sage P; Laumonier H; Couchy G; Le Bail B; Sa Cunha A; Rullier A; Laurent C; Blanc JF; Cubel G; Trillaud H; Zucman-Rossi J; Balabaud C; Saric J
Hepatology; 2009 Aug; 50(2):481-9. PubMed ID: 19585623
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.
Margolskee E; Bao F; de Gonzalez AK; Moreira RK; Lagana S; Sireci AN; Sepulveda AR; Remotti H; Lefkowitch JH; Salomao M
Diagn Pathol; 2016 Mar; 11():27. PubMed ID: 26961851
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
Shafizadeh N; Genrich G; Ferrell L; Kakar S
Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic characterization of hepatocellular adenomas in men: a multicenter experience.
González IA; Torbenson M; Sharifai N; Byrnes K; Chatterjee D; Kakar S; Yeh MM; Wu TT; Zhang X; Jain D
Hum Pathol; 2023 Aug; 138():24-33. PubMed ID: 37245629
[TBL] [Abstract][Full Text] [Related]
18. Retrospective study of hepatocellular adenomas based on the phenotypic classification system: A report from China.
Pan J; Chen L; Fan J; Zhou J; Qin L; Tan Y; Ji Y; Huang X
Histol Histopathol; 2014 Feb; 29(2):243-9. PubMed ID: 23939475
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular adenomas: review of pathological and molecular features.
Beaufrère A; Paradis V
Hum Pathol; 2021 Jun; 112():128-137. PubMed ID: 33307077
[TBL] [Abstract][Full Text] [Related]
20. Coexistence of inflammatory hepatocellular adenomas with HNF1α-inactivated adenomas: is there an association?
Castain C; Sempoux C; Brunt EM; Causse O; Heitzmann A; Hernandez-Prera JC; Le Bail B; Schirmacher P; Thung SN; Balabaud C; Bioulac-Sage P
Histopathology; 2014 May; 64(6):890-5. PubMed ID: 24236804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]